These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
140 related items for PubMed ID: 2834571
1. Relationship between plasma levels of atrial natriuretic peptide and cyclic guanosine monophosphate in patients with heart diseases. Nakaoka H, Imataka K, Kitahara Y, Fujii J, Ishibashi M, Yamaji T. Jpn Circ J; 1988 Jan; 52(1):30-4. PubMed ID: 2834571 [Abstract] [Full Text] [Related]
2. [Effect of digoxin on atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP) and cyclic 3', 5'-guanosine monophosphate (cGMP) in patients with chronic congestive heart failure]. Kobusiak-Prokopowicz M, Swidnicka-Szuszkowska B, Mysiak A. Pol Arch Med Wewn; 2001 Jun; 105(6):475-82. PubMed ID: 11865578 [Abstract] [Full Text] [Related]
3. Uncoupling of atrial natriuretic peptide extraction and cyclic guanosine monophosphate production in the pulmonary circulation in patients with severe heart failure. Tsutamoto T, Kanamori T, Wada A, Kinoshita M. J Am Coll Cardiol; 1992 Sep; 20(3):541-6. PubMed ID: 1324959 [Abstract] [Full Text] [Related]
4. Increased plasma cyclic guanosine monophosphate concentrations in children with high levels of circulating atrial natriuretic peptide. Weil J, Gerzer R, Strom T, Lang RE, Döhlemann C, Knorr D, Bidlingmaier F. Pediatrics; 1987 Oct; 80(4):545-8. PubMed ID: 2821478 [Abstract] [Full Text] [Related]
5. Correlation of atrial natriuretic peptide and cyclic guanosine monophosphate plasma concentrations in patients with heart disorders during rest and exercise. Szekeres T, Artner-Dworzak E, Puschendorf B, Fritzer M, Havel M, Gassner A, Fridrich L. Eur J Clin Chem Clin Biochem; 1993 Feb; 31(2):69-74. PubMed ID: 8385504 [Abstract] [Full Text] [Related]
6. Plasma atrial natriuretic peptide levels in children with cardiac diseases: correlation with cGMP levels and haemodynamic parameters. Weil J, Strom TM, Brangenberg R, Sebening W, Haufe M, Lang RE, Bidlingmaier F, Gerzer R. Horm Res; 1987 Feb; 28(1):64-70. PubMed ID: 2834283 [Abstract] [Full Text] [Related]
7. [Values of atrial natriuretic peptide (ANP) and cyclic guanosine monophosphate (cGMP) in cardioversion]. Lechleitner P, Genser N, Hauptlorenz S, Putensen C, Mitterschiffthaler G, Artner-Dworzak E, Puschendorf B, Dienstl F. Z Kardiol; 1991 Sep; 80(9):574-9. PubMed ID: 1661054 [Abstract] [Full Text] [Related]
8. Limitations of compensation by endogenous atrial natriuretic peptide in heart failure. Tsutamoto T, Kanamori T, Wada A, Miyauchi N, Murata T, Kinoshita M. Jpn Circ J; 1992 May; 56(5):489-93. PubMed ID: 1318429 [Abstract] [Full Text] [Related]
17. Clinical significance of natriuretic peptides and cyclic GMP in hemodialysis patients with coronary artery disease. Osajima A, Okazaki M, Kato H, Anai H, Tsuda Y, Segawa K, Tanaka H, Tamura M, Takasugi M, Nakashima Y. Am J Nephrol; 2001 Oct; 21(2):112-9. PubMed ID: 11359018 [Abstract] [Full Text] [Related]
18. Heart is the Target Organ of Endogenous Cardiac Natriuretic Peptides. Tsutamoto T, Sakai H, Yamamoto T, Nakagawa Y. Int Heart J; 2020 Jan 31; 61(1):77-82. PubMed ID: 31956150 [Abstract] [Full Text] [Related]
19. Plasma concentrations of atrial and brain natriuretic peptides and cyclic guanosine monophosphate in response to dobutamine infusion in patients with surgically repaired tetralogy of fallot. Hayabuchi Y, Matsuoka S, Kuroda Y. Pediatr Cardiol; 1999 Jan 31; 20(5):343-50. PubMed ID: 10441688 [Abstract] [Full Text] [Related]